Managing Adverse Events With Trastuzumab Deruxtecan: Early Detection and ILD Monitoring Strategies

Experts discuss the most common adverse events associated with trastuzumab deruxtecan, how to effectively identify and manage them to minimize treatment interruptions, and how to monitor and address interstitial lung disease (ILD), a known potential adverse effect of trastuzumab deruxtecan.